|
W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER
|
Back to Search Results |
|
| Catalog Number |
DSF2433 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
11/04/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
The following information was reported to gore: on (b)(6) 2021, the patient underwent endovascular treatment for a thoracic aortic aneurysm using the gore® tag® conformable thoracic stent graft with active control system (ctag).The patient¿s abdominal aorta had been replaced with a y-shaped synthetic graft, and a 10 mm diameter synthetic graft (manufacturer unknown) was used as a conduit.On an unknown date, enlargement of the vessel diameter at the distal end of the previously implanted ctag was observed.On (b)(6) 2025, the patient underwent reintervention.(addressed in #2017233-2025-06848.) the ligated portion of the previous conduit was transected and anastomosed to a new synthetic graft (manufacturer unknown).Upon insertion of a 24 fr gore® dryseal flex introducer sheath (dsf), resistance was encountered near the anastomosis between the y-shaped synthetic graft and the previous conduit, and the dsf was advanced through the site with applied force.The first ctag was deployed distally, but its distal end was positioned more proximally than intended.After deploying the second ctag, a distal type i endoleak was observed.A touch-up procedure was performed, resulting in a slight residual distal type i endoleak.Following dsf removal, angiography revealed blood leakage near the anastomosis site.The area was surgically repaired, and the procedure was completed.
|
| |
|
Search Alerts/Recalls
|
|
|